Irvin Mark Modlin
11Patents
2h-index
2Co-inventors
36Inventor score
Filing activity: Sep 3, 2013 → Jul 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10407730B2 | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | Chemistry; Metallurgy | 3 | Active |
| US11168372B2 | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | Chemistry; Metallurgy | 2 | Active |
| US11414707B2 | Methods for colon cancer detection and treatment | Chemistry; Metallurgy | 1 | Active |
| US9988684B2 | Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) | Physics | 0 | Active |
| US12366575B2 | Chemical compositions and methods of use | Physics | 0 | Active |
| US11744907B2 | Predicting peptide receptor radiotherapy using a gene expression assay | Chemistry; Metallurgy | 0 | Active |
| US12399179B2 | Chemical compositions and methods of use | Physics | 0 | Active |
| US12305240B2 | Methods for colon cancer detection and treatment | Chemistry; Metallurgy | 0 | Active |
| US11410748B2 | Methods for prostate cancer detection and treatment | Physics | 0 | Active |
| US12258633B2 | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | Chemistry; Metallurgy | 0 | Active |
| US10709714B2 | Gastrin antagonists for treatment and prevention of osteoporosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.